During the past decade, Beijing Pinggu Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 2 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 2 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beijing Pinggu Hospital" #1 sponsor was "Peking University" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "China Agricultural University" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Ark Biosciences Inc." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beijing Pinggu Hospital" #1 collaborator was "Beijing Pinggu District Hospital" with 2 trials as a collaborator, "Centers for Disease Control and Prevention, China" with 2 trials as a collaborator, "Peking University Health Science Center Hospital" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Beijing Chinese Medicine Hospital-Pinggu Hospital" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Beijing Pinggu Hospital" are "Diabetes Mellitus, Type 2" (3 trials), "Type 2 Diabetes Mellitus" (3 trials), "SARS-CoV-2" (2 trials), "Type 2 Diabetes" (2 trials) and "Type 2 Diabetes Mellitus (T2DM)" (2 trials). Many other conditions were trialed in "Beijing Pinggu Hospital" in a lesser frequency.

Most popular intervention types in "Beijing Pinggu Hospital" are "Drug" (13 trials), "Dietary Supplement" (4 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Acarbose" (3 trials), "Insulin Glargine" (2 trials), "Vildagliptin" (2 trials) and "1 week of probiotics(Week 1)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beijing Pinggu Hospital" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Beijing Pinggu Hospital". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Beijing Pinggu Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Beijing Pinggu Hospital, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".